These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3195293)

  • 1. [Sidnocarb treatment of young schoolchildren with the hyperdynamic syndrome].
    Krasov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(8):97-101. PubMed ID: 3195293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG changes after mesocarb in respondent and nonrespondent hyperkinetic children.
    Drtílková I; Misurec J; Balastíková B; Náhunek K; Výborová L; Sindelárová M
    Act Nerv Super (Praha); 1989 Apr; 31(1):50. PubMed ID: 2782000
    [No Abstract]   [Full Text] [Related]  

  • 3. [Excretion of monoamines, their precursors and metabolites in the hyperactivity syndrome in mentally defective children].
    Turova NF; Misionzhnik EIu; Ermolina LA; Aziavchik AV; Krasov VA
    Vopr Med Khim; 1988; 34(1):47-50. PubMed ID: 3369126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of sidnocarb and dihydroergotamine during 6-hour head-down tilt hypokinesia on human physical work capacity].
    Anashkin OD; Amel'kina GV; Modin AIu
    Kosm Biol Aviakosm Med; 1983; 17(2):93-5. PubMed ID: 6855181
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of psychotropic preparations on the behavior of inbred mice under emotional stress].
    Seredenin SB; Vedernikov AA
    Biull Eksp Biol Med; 1979 Jul; 88(7):38-40. PubMed ID: 37945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience with new psychostimulant - Sydnocarb].
    Bach O; Petermann H; Heber I
    Psychiatr Neurol Med Psychol (Leipz); 1976 Oct; 28(10):609-14. PubMed ID: 798218
    [No Abstract]   [Full Text] [Related]  

  • 7. Discussion on integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD).
    Hendren RL
    Essent Psychopharmacol; 2005; 6(5):291-300. PubMed ID: 16222913
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and experimental experiences with maprotiline, clomipramine, sydnocarb and mefexamide in mentally-ill patients and in healthy persons].
    Zapletálek M; Hübsch T; Zbytovský J; Polácková J; Kindernayovä H
    Schweiz Arch Neurol Neurochir Psychiatr; 1977; 120(2):323-34. PubMed ID: 333568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperkinetic syndrome in childhood. Diagnostic and psychopharmaceutical treatment].
    Hundevadt L
    Tidsskr Nor Laegeforen; 1986 Sep; 106(25):2023-6. PubMed ID: 3775723
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of fenazepam and sidnocarb in the phantom pain syndrome].
    Danilova EI; Grafova VN; Reshetnik VK
    Eksp Klin Farmakol; 1994; 57(1):11-3. PubMed ID: 7908239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of sidnocarb on learning and memory].
    Ganiev MM; Kharlamov AN; Raevskiĭ KS; Guseĭnov DIa
    Biull Eksp Biol Med; 1987 Oct; 104(10):453-4. PubMed ID: 3676468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and electroencephalographic features of the action of the psychic stimulant sydnocarb in various forms of epilepsy].
    Biniaurishvili RG; Veĭn AM; Chalkov VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(6):886-91. PubMed ID: 6431728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
    Weller EB; Rowan A; Elia J; Weller RA
    J Clin Psychiatry; 1999; 60 Suppl 15():5-11. PubMed ID: 10418807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of enuresis with sydnocarb.
    Polák L; Skoricová M; Dimová N; Havlícková H; Okruhlica L; Molcan J
    Act Nerv Super (Praha); 1981 Dec; 23(4):263-4. PubMed ID: 7336856
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacotherapy of attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience with the use of sidnocarb in child psychiatry].
    Linka Z
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):278-80. PubMed ID: 1119270
    [No Abstract]   [Full Text] [Related]  

  • 18. [A therapeutic study of sidnocarb tablets].
    Kleĭn M; Sobor A
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):275-8. PubMed ID: 1119269
    [No Abstract]   [Full Text] [Related]  

  • 19. The mislabeled child.
    Eide BL; Eide FF
    New Atlantis; 2006; 12():46-59. PubMed ID: 16832954
    [No Abstract]   [Full Text] [Related]  

  • 20. [The cardinal symptom. Difficulties in concentration of schoolchildren].
    Ergardt KG
    Servir; 1986; 34(2):66-71. PubMed ID: 3090691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.